Strategy | Expected Cost (95% CI) | Expected QALYs (95% CI) | ∆C | ∆QALYs | ICUR ($/QALY) |
---|---|---|---|---|---|
1% increase in deceased donor KT evaluated over a lifetime | |||||
 Deemed consent | $308,516 ($177,627 to $555,362) | 3.86 (2.92 to 4.55) | $349 | 0.01 | 32,629 (95% CI:  − 64,279 to 232,488) Probability of cost-effectiveness if WTP is 61,466: 81% |
 Expressed consent | $308,167 ($177,663 to $553,897) | 3.85 (2.92 to 4.54) | |||
1% increase in deceased donor KT evaluated over five years | |||||
 Deemed consent | $192,453 ($113,063 to $336,939) | 2.16 (1.72 to 2.48) |  − $319 | 0.01 | Expressed consent dominated |
 Expressed consent | $192,772 ($113,367 to 336,276) | 2.15 (1.72 to 2.48) | |||
26% increase in deceased donor KT evaluated over a lifetime | |||||
 Deemed consent | $319,824 ($177,541 to $608,737) | 4.15 (3.06 to 4.92) | $11,657 | 0.30 | 38,594 (95% CI: − 41,022 to 220,930) Probability of cost-effectiveness if WTP is 61,466: 80% |
 Expressed consent | $308,167 ($177,663 to $553,897) | 3.85 (2.92 to 4.54) | |||
26% increase in deceased donor KT evaluated over 5Â years | |||||
 Deemed consent | $185,057 ($108,603 to $331,539) | 2.20 (1.69 to 2.56) |  − $7,715 | 0.05 | Expressed consent dominated |
 Expressed consent | $192,772 ($116,974 to 324,983) | 2.15 (1.69 to 2.50) |